Patents-Review.com
ClassID:

170629 ⎘

G01N2333/91171 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5) general (2.5.1) with definite EC number (2.5.1.-)

Sub-classes:
Recent Application in this class:
#1
20220380831
2022-12-01

PRENYLATION ASSAY

 #2
20200341015
2020-10-29

PRENYLATION ASSAY

 #3
20190017096
2019-01-17

PRENYLATION ASSAY

 #4
20180246116
2018-08-30

Methods of detecting and measuring glutamine and analogues thereof, and methods related thereto

 #5
20180135097
2018-05-17

Rab Escort Protein potency assay

 #6
20170199199
2017-07-13

Compositions and methods for regulating glucose metabolism

 #7
20170007561
2017-01-12

CONTEMPORANEOUS, HETEROGENEOUSLY-ORIENTED, MULTI-TARGETED THERAPEUTIC MODIFICATION AND/OR MODULATION OF DISEASE BY ADMINISTRATION OF SULFUR-CONTAINING, AMINO ACID-SPECIFIC SMALL MOLECULES

 #8
20160299151
2016-10-13

Methods of detecting and measuring glutamine and analogues thereof, and methods related thereto

 #9
20160230178
2016-08-11

cell line with thyA knockout, folA knockout, and one or both of folP knockout, and folK knockout

 #10
20160010143
2016-01-14

METHOD FOR DETECTING PYROPHOSPHATE BY MEANS OF BIOLUMINESCENCE DETECTION

 #11
20150338411
2015-11-26

Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment

 #12
20150241411
2015-08-27

IDENTIFICATION OF ENZYME ACTIVITY THROUGH DETERMINATION OF ITS LOCALIZATION

 #13
20150024973
2015-01-22

Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment

 #14
20120329066
2012-12-27

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

 #15
20110124519
2011-05-26

METHOD OF ASSESSING KIDNEY FUNCTION IN A HUMAN SUBJECT

 #16
20110045490
2011-02-24

Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment

 #17
20110027806
2011-02-03

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

 #18
20100092966
2010-04-15

Method for detecting pyrophosphate by means of bioluminescence detection

 #19
20100081145
2010-04-01

Detecting Prostate Cancer

 #20
20090247634
2009-10-01

Methods for identifying modulators of eoxin formation

 #21
20090104638
2009-04-23

Methods for Building Atomic Models of Protein Molecules and Determining Drug Candidates Using MGST1

 #22
20080254455
2008-10-16

DETECTING PROSTATE CANCER

 #23
20080131375
2008-06-05

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

 #24
20070154963
2007-07-05

Method to determine whether a compound is a cellular GSTpi inhibitor

 #25
20060257951
2006-11-16

Use of protein spee as a marker for breast cancer

 #26
20060188950
2006-08-24

Use of protein spee as a marker for colorectal cancer

 #27
20050221459
2005-10-06

Geranylgeranyl transferase type I (GGTase-I) structure and uses thereof

 #28
20050026158
2005-02-03

Methods of diagnosing and treating hepatic cell proliferative disorders